Compare Novo Nordisk A/S (NVO) vs Stitch Fix Inc (SFIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novo Nordisk A/S vs Stitch Fix Inc — how do they compare? Novo Nordisk A/S trades at $46.01 (market cap $207.85B), while Stitch Fix Inc trades at $3.63 (market cap $497.68M). The key difference: Novo Nordisk A/S is far larger — about 417.6× Stitch Fix Inc's market cap, and Novo Nordisk A/S pays a 3.81% dividend while Stitch Fix Inc pays none. Which is the better fit depends on your goals.
| NVO | SFIX | |
|---|---|---|
Market Cap | $207.85B | $497.68M |
Sector | Health | Consumer Cyclical |
52-Week High | $63.98 | $5.83 |
52-Week Low | $35.29 | $3.06 |
Enterprise Value | $222.55B | $385.40M |
Dividend Yield | 3.81% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NVO trades at $47.73, up 0.99% today, with a neutral technical signal and strong fundamentals, including a P/E of 11.62 and net income margin of 35.35%. Recent Q2 2026 earnings beat expectations, but the stock faces mixed sentiment due to competitive pressures and pricing headwinds in its GLP-1 portfolio.
The outlook is cautiously optimistic, supported by robust profitability and analyst buy ratings (57.9%), but risks include intense competition from Eli Lilly and margin compression. Upside potential hinges on execution against guidance, while downside risks stem from market share erosion.
Stitch Fix (SFIX) trades at $3.97, down 5.48% today, as the online personal styling service shows mixed signals. While revenue has stabilized around $1.3B annually and losses are narrowing significantly, the company remains unprofitable with a -1.43% net margin. Technical indicators show a bullish trend with strong momentum signals, though oscillators remain neutral. Recent news highlights AI-driven personalization initiatives and active client growth as potential turnaround catalysts.
The stock presents a speculative recovery opportunity with improving fundamentals but carries execution risks. Analyst consensus is cautious with a $4.75 price target (20% upside) but only 27% buy ratings. Key risks include consumer spending pressure and the challenge of achieving sustainable profitability in the competitive retail sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →About Stitch Fix Inc
Stitch Fix Inc offers personal style service for men and women. The company engages in delivering one-to-one personalization to clients through the combination of data science and human judgment. It provides a shipment service called A FIX where the stylist's hand selects items from several merchandises with analysis of client and merchandise data to provide a personalized shipment of apparel, shoes, and accessories suited to the client's needs. The company offers products across categories, brands, product types and price points including Women's, Petite, Maternity, Men's and Plus. It also offers various product types, including denim, dresses, blouses, skirts, shoes, jewelry and handbags, and sells merchandise across various range of price points.
Read more on SFIX →
